Viewing Study NCT05619861


Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2025-12-27 @ 9:53 PM
Study NCT ID: NCT05619861
Status: UNKNOWN
Last Update Posted: 2022-11-17
First Post: 2022-11-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CAR-T Cells in the Treatment of Malignant Hematological Tumors
Sponsor: Hebei Senlang Biotechnology Inc., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module